Original articleSerum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer
References (22)
- et al.
Pre-treatment prognostic factors in Stage III non-small cell lung cancer patients receiving combined modality treatment
Int J Radiat Oncol Biol Phys
(1991) The MIC regimen in non-small cell lung cancer
Lung Cancer
(1993)Metastatic non-small cell lung cancer
Lung Cancer
(1993)Rationale for the treatment of non-small cell lung cancer
Lung Cancer
(1993)Current perspectives in the treatment of non-small cell lung cancer
Lung Cancer
(1993)Current treatment of unresectable lung cancer
- et al.
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
Eur J Cancer
(1991) - et al.
Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology group experience
J Clin Oncol
(1991) - et al.
Combination chemotherapy with ifosfamide, mitomycin and cisplatin in advanced non-small cell lung cancer
Cancer Treat Rep
(1987) - et al.
Cancer of the lung
Prognostic significance of the expression of ras oncogen product in non-small cell lung cancer
Cancer
(1992)
Cited by (0)
Copyright © 1995 Published by Elsevier Ireland Ltd.